The upscheduling of combination analgesics containing codeine: The impact on the practice of pharmacists
Tài liệu tham khảo
Reed, 2011
Nielsen, 2012, OTC codeine: examining the evidence for and against, Aust Pharm, 31, 236
McDonough, 2011, Misuse of codeine-containing combination analgesics, Med J Aust, 194, 486, 10.5694/j.1326-5377.2011.tb03069.x
Frei, 2010, Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases, Med J Aust, 193, 294, 10.5694/j.1326-5377.2010.tb03911.x
Daly, 2008, Guidelines for the management of paracetamol poisoning in Australia and New Zealand – explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres, Med J Aust, 188, 296, 10.5694/j.1326-5377.2008.tb01625.x
Chetty, 2003, Severe hypokalaemia and weakness due to Nurofen misuse, Ann Clin Biochem, 40, 422, 10.1258/000456303766477101
Dutch, 2008, Nurofen Plus misuse: an emerging cause of perforated gastric ulcer, Med J Aust, 188, 56, 10.5694/j.1326-5377.2008.tb01509.x
Dyer, 2004, Hypokalaemia in ibuprofen and codeine phosphate abuse, Int J Clin Pract, 58, 1061, 10.1111/j.1368-5031.2004.00304.x
Ernest, 2010, Profound hypokalaemia due to Nurofen Plus and Red Bull misuse, Crit Care Resusc, 12, 109
Lambert, 2005, Life-threatening hypokalaemia from abuse of Nurofen Plus, J R Soc Med, 98, 21, 10.1258/jrsm.98.1.21
The Pharmacy Guild of Australia. Australia's Unique Medication Scheduling System. Available at: http://www.guild.org.au/iwov-resources/documents/The_Guild/PDFs/News%20and%20Events/Publications/Fact%20Sheets/scheduling_system.pdf; Accessed 29.09.12.
Tan, 2009, Non-prescription medicines: current issues in Australian community pharmacy, Int J Pharm Pract, 17, 207, 10.1211/ijpp.17.04.0003
Norris, 2004, New Zealand pharmacists and pharmacist-only medicines, J Pharm Pract Res, 34, 282, 10.1002/jppr2004344282
Therapeutic Goods Administration. Codeine Rescheduling – Information for Sponsors. Available at: http://www.tga.gov.au/industry/otc-codeine-rescheduling-100224.htm; Accessed 06.10.12.
Hanna, 2010, First, do no harm: factors that influence pharmacists making decisions about over-the-counter medication: a qualitative study in Northern Ireland, Drug Saf, 33, 245, 10.2165/11319050-000000000-00000
Akram, 2003, Pharmacists management of over-the-counter medication requests from methadone patients, J Subst Use, 8, 215, 10.1080/14659890310001636044
MacFayden, 2001, Community pharmacists' experience of over-the-counter medicine misuse in Scotland, J R Soc Promot Health, 121, 185, 10.1177/146642400112100316
Wazaify, 2006, The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland, Patient Educ Couns, 64, 136, 10.1016/j.pec.2005.12.008
Nielsen, 2010
McBride, 2003, Delphi survey of experts' opinions on strategies used by community pharmacists to reduce over-the-counter drug misuse, Addiction, 98, 487, 10.1046/j.1360-0443.2003.00345.x
Albsoul-Younes, 2010, Abuse and misuse of prescription and nonprescription drugs sold in community pharmacies in Jordan, Subst Use Misuse, 45, 1319, 10.3109/10826080802490683
Smith, 2005
Crosby, 2006
Neergaard, 2009, Qualitative description – the poor cousin of health research?, BMC Med Res Methodol, 9, 52, 10.1186/1471-2288-9-52
Carlson, 2010, Avoiding traps in member checking, Qual Rep, 15, 1102
The Pharmacy Guild of Australia. Project Stop. Available at: http://www.projectstop.com/; Accessed 06.10.12.
2012
Sproule, 2011, Decreasing the harms of prescription opioids: a case for pharmacists, Drug Alcohol Rev, 30, 327, 10.1111/j.1465-3362.2010.00270.x
Lafferty, 2006, Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse, J Psychoactive Drugs, 38, 229, 10.1080/02791072.2006.10399848
Morris, 1997, “One simple question should be enough”: consumers' perceptions of pharmacy protocols, Int J Pharm Pract, 5, 64, 10.1111/j.2042-7174.1997.tb00887.x
Hughes, 2003, Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment, Br J Gen Pract, 53, 600
Carter, 2008, A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control, J Clin Hypertens (Greenwich), 10, 260, 10.1111/j.1751-7176.2008.07434.x
Ramser, 2008, Physician-pharmacist collaboration in the management of patients with diabetes resistant to usual care, Diabetes Spectr, 21, 209, 10.2337/diaspect.21.3.209
Benavides, 2009, Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present, Ann Pharmacother, 43, 85, 10.1345/aph.1K612